These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 26430894

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK, Alex M, Czerny CP, Böhm R, Beyer W.
    Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 7. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
    Price BM, Liner AL, Park S, Leppla SH, Mateczun A, Galloway DR.
    Infect Immun; 2001 Jul; 69(7):4509-15. PubMed ID: 11401993
    [Abstract] [Full Text] [Related]

  • 8. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J, Grover S, Goel D, Rahi A, Jayadev Magani SK, Chandra S, Bhatnagar R.
    Vaccine; 2011 Jun 15; 29(27):4521-33. PubMed ID: 21504775
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
    Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.
    Infect Immun; 2009 Mar 15; 77(3):1197-207. PubMed ID: 19114543
    [Abstract] [Full Text] [Related]

  • 10. BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge.
    Köhler SM, Baillie LW, Beyer W.
    Vaccine; 2015 Jun 04; 33(24):2771-7. PubMed ID: 25917676
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.
    Hahn UK, Boehm R, Beyer W.
    Vaccine; 2006 May 22; 24(21):4569-71. PubMed ID: 16157424
    [Abstract] [Full Text] [Related]

  • 12. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
    Yin Y, Zhang J, Dong D, Liu S, Guo Q, Song X, Li G, Fu L, Xu J, Chen W.
    Vaccine; 2008 Oct 29; 26(46):5814-21. PubMed ID: 18786589
    [Abstract] [Full Text] [Related]

  • 13. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL.
    Microb Pathog; 2005 Oct 29; 38(5-6):209-25. PubMed ID: 15925272
    [Abstract] [Full Text] [Related]

  • 14. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE.
    FEMS Immunol Med Microbiol; 2009 Nov 29; 57(2):165-72. PubMed ID: 19732139
    [Abstract] [Full Text] [Related]

  • 15. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD, Wilder JA, Mega WM, Hutt JA, Kuehl PJ, Valderas MW, Chew LL, Liang BC, Squires CH.
    PLoS One; 2015 Nov 29; 10(7):e0130952. PubMed ID: 26207820
    [Abstract] [Full Text] [Related]

  • 16. Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague.
    Albrecht MT, Livingston BD, Pesce JT, Bell MG, Hannaman D, Keane-Myers AM.
    Vaccine; 2012 Jul 06; 30(32):4872-83. PubMed ID: 22633906
    [Abstract] [Full Text] [Related]

  • 17. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW, Rodriguez AL, Moore S, Atkins HS, Feng C, Nataro JP, Pasetti MF.
    Vaccine; 2008 Nov 11; 26(48):6083-91. PubMed ID: 18805452
    [Abstract] [Full Text] [Related]

  • 18. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, Decker WK.
    Vaccine; 2008 Jan 30; 26(5):614-22. PubMed ID: 18166249
    [Abstract] [Full Text] [Related]

  • 19. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
    Wang HC, An HJ, Yu YZ, Xu Q.
    Immunol Lett; 2015 Feb 01; 163(2):206-13. PubMed ID: 25102364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.